drugset / Trial / NCT02632630

Nutrition Supplementation in Hospitalized Patients

NCT02632630

RandomizedFactorialOpen-labelTreatment

Summary

Patients with severe malnutrition risk are 7.4 times more likely to die in hospital than well-nourished patients, and carry a 30-day readmission rate of \>46%. Although malnutrition is common and is associated with extremely poor outcomes, it is neglected and undertreated. This is a randomized controlled pilot trial to rapidly identify at-risk hospitalized medical patients, and then provide nutritional supplementation in hospital and after discharge for 28 days. In select at-risk patients, 5 days of nutrition delivered through a peripheral vein will be used in addition to oral nutritional supplementation.

Timeline

Start
2016-03
Primary completion
2018-02
Completion
2018-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dextrose Unknown Intravenous
Comparator Peri-OLIMEL 2.5% E Unknown Intravenous
Comparator Ringer's Lactate Other / unclassified Intravenous
Comparator sodium chloride Unknown Intravenous